Plasma From Older Children in Malawi Inhibits Plasmodium falciparum Binding in 3-Dimensional Brain Microvessels

Fatou Joof1, Ruoqian Hu2, Alex Saidi3

  • 1Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA.

Insights

Functional antibodies can block Plasmodium falciparum sequestration in the brain, a key feature of cerebral malaria. Antibody levels correlate with reduced parasite binding, indicating acquired immunity against cerebral malaria variants.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Neuroscience

Background:

  • Cerebral malaria, a severe complication of Plasmodium falciparum infection, is characterized by parasite-infected erythrocyte sequestration in the brain.
  • Antibodies are crucial for malaria immunity, but their role in blocking cytoadhesion in the brain microvasculature remains incompletely understood.

Purpose of the Study:

  • To investigate the functional antibody response against Plasmodium falciparum-infected erythrocytes (IEs) and its ability to inhibit cytoadhesion in a human brain microvessel model.
  • To determine the correlation between antibody reactivity to IE surface antigens and adhesion-blocking activity.

Main Methods:

  • Screening of plasma from Malawian children and young adults for antibodies targeting the P. falciparum-IE surface using flow cytometry.
  • Utilizing a bioengineered 3D human brain microvessel model with variable flow dynamics to quantify IE adhesion and measure antibody-mediated inhibition.

Main Results:

  • A strong correlation was observed between high surface antibody reactivity and reduced P. falciparum-IE binding in the 3D brain microvessel model.
  • A specific threshold of surface antibody reactivity was necessary to achieve significant inhibition of IE adhesion.
  • Flow dynamics within the microvessels influenced the quality of the antibody-mediated inhibitory response.

Conclusions:

  • Individuals exposed to stable P. falciparum transmission acquire functional antibodies that can block IE cytoadhesion to the brain vasculature.
  • The efficacy of these adhesion-blocking antibodies is dependent on their reactivity level and influenced by microenvironmental factors like flow dynamics.
  • These findings highlight the potential of targeting adhesion mechanisms for cerebral malaria prevention and treatment.